• Home
  • Services
    • Support Options
    • OnRequest Support
    • In-Vitro
    • In-Vivo
    • Ex-Vivo
    • Histology
  • Company
    • Meet The Team
    • Values & Commitments
    • About US
    • Message from the CEO
    • Photo Gallery
  • Resources
    • FAQ's
    • What is a cell assay?
    • What is a kinase??
    • Kinase Figures
    • Epigenetic Assays
    • Migration assay
    • Kinase Assays
    • NanoBRET
    • Cell Lines Top 10 Cancer
  • Contact
  • More
    • Home
    • Services
      • Support Options
      • OnRequest Support
      • In-Vitro
      • In-Vivo
      • Ex-Vivo
      • Histology
    • Company
      • Meet The Team
      • Values & Commitments
      • About US
      • Message from the CEO
      • Photo Gallery
    • Resources
      • FAQ's
      • What is a cell assay?
      • What is a kinase??
      • Kinase Figures
      • Epigenetic Assays
      • Migration assay
      • Kinase Assays
      • NanoBRET
      • Cell Lines Top 10 Cancer
    • Contact

  • Home
  • Services
    • Support Options
    • OnRequest Support
    • In-Vitro
    • In-Vivo
    • Ex-Vivo
    • Histology
  • Company
    • Meet The Team
    • Values & Commitments
    • About US
    • Message from the CEO
    • Photo Gallery
  • Resources
    • FAQ's
    • What is a cell assay?
    • What is a kinase??
    • Kinase Figures
    • Epigenetic Assays
    • Migration assay
    • Kinase Assays
    • NanoBRET
    • Cell Lines Top 10 Cancer
  • Contact

Meet The Team

Antimone Dewing, PhD

 Dr. Antimone Dewing

Chief Executive & Scientific Officer

 Antimone is a native Californian and has been a vital member of the Southern CA scientific community for over thirty years. 

Her diverse experience, including significant management and scientific leadership roles in academic institutions, commercial research organizations, and start-up biotechnology companies have forged her strategic and innovative approaches to the development 

and validation of novel therapies. ​

Through exceptional vision and creativity, 

Dr. Dewing has managed labs and core departments for industry leaders such as 

Veterans Medical Research Foundation, 

Sanford Burnham Medical Research Institute, Crown Bio International, and now 

Eutheria Bioscience.  

Dr. Dewing models a rigorous yet empathetic leadership; creating proficient and productive teams who strive in turning challenging problems into creative solutions.

Rico Solano, MBA

 Rico Solano, Chief Operating Officer 

Rico has a decade of experience as a scientist across various disciplines including: academia, high throughput drug screening, biotechnology startup, and contract research. 

Prior to founding Eutheria Bioscience, Rico managed a $2M commercial laboratory supply territory which, under his command, expanded to over $7M in the course of 2 years.  

As COO, Rico will be an integral part of the company's operational development and growth, in line with our mission and core value 

to let science results drive business 

decisions in the industry. 

Rico earned his B.S. in Biochemistry and his 

MBA from Point Loma Nazarene University.

Louis Procida

 Louis Procida,  Chief Financial Officer  

Mr. Procida has 30 years of experience in the securities and commodities industry. Starting his career at a young age in hedge trading in the Cocoa market for large industry leaders such as Merrill Lynch, Hershey’s, Genco Cocoa, and Barry Callebut.  Lou was a former member of the New York Board of Trade now known as The Ice Exchange and continues to maintain 

relationships with the Wall Street Hedge Fund. 

Included in his many talents: writing and programming analytical trading programs; structuring financial analysis data for fund raising projects within the renewable energy technologies market; Fixed Income Securities; Government Trading Operations liaison, Assistant Trader on Mortgage-Backed Securities Desk, and Registered Representative Retail Trader of Collateralized Mortgage Obligations(CMO’s). Team member in underwriting structure of new issuance CMO’s ($100mm+). US Trust: Redeemable bond specialist. Dean Witter Reynolds: Fixed Income Securities; Government Trading Operations.

Eutheria Bioscience

Founded by Scientists for Scientists

858-230-6092

Copyright © 2022 Eutheria Bioscience - All Rights Reserved.

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept